Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global CRISPR technologies market was valued at USD 3.40 Billion in 2023. It is expected to grow at a CAGR of 16.10% during the forecast period of 2024-2032 and attain a market value of USD 13.03 Billion by 2032. The growing number of active clinical studies around the world is predicted to drive the growth of global CRISPR technology patents over the forecast period. For example, in March 2021, scientists at the UC San Francisco (University of California, San Francisco), UC Berkeley, and UCLA (the University of California, Los Angeles) received the United States Food and Drug Administration (FDA) approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease (SCD) by using the patient's own blood-forming stem cells. Such technologies are poised to boost the number of patent applications significantly in the coming years.
The Global CRISPR Technologies Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for CRISPR Technologies include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with CRISPR Technologies. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within CRISPR Technologies.
An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis of CRISPR technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with CRISPR technologies.
A comprehensive summary of several patent applications which were filed across different jurisdictions for CRISPR technologies, and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.
Detailed analysis of the granted patents across different jurisdictions for CRISPR technologies and their relative value in the IP are covered in the final report.
CRISPR, or "Clustered Regularly Interspaced Short Palindromic Repeats," is a groundbreaking gene-editing technology that enables scientists to precisely manipulate DNA within live creatures. CRISPR technology uses RNA molecules and the Cas9 protein to target and edit certain genes. It has grown in prominence due to its efficiency, precision, and versatility in a wide range of applications, including biomedical research, gene therapy, agriculture, and functional genomics. The CRISPR technology industry has grown dramatically, driven by advances in genome editing, increased biotechnology investments, and a growing need for precise gene-editing tools across a wide range of businesses.
CRISPR technology is increasingly being used in industrial contexts for bio-manufacturing, including the manufacture of biofuels and industrial enzymes, leading to an increased number of patent applications. Its market share in various applications is growing, solidifying its position as a prominent category. CRISPR-based solutions improve efficiency in industrial operations, which contributes to the growth of this application category. However, regulatory concerns and public perceptions provide barriers to wider adoption in specific industrial uses. Biological research, including functional genomics and basic research, is a key application area for CRISPR technology. This area is characterized by continuous innovation, making it a significant contributor to patent progress. CRISPR's versatility in investigating gene functions and biological systems ensures its continued use in scientific applications.
Rising Investments in Healthcare Companies and Advancement in Genome Editing is Expected to Boost the Patent Industry Growth
The CRISPR technology patent industry has grown significantly as genome editing advances. Continuous research has resulted in the development of CRISPR procedures, making them more accurate and adaptable. This progress has not only increased usage across a wide range of applications but has also fueled the overall expansion of the CRISPR technology market. The tremendous expansion in biotechnology and healthcare spending from both the private and public sectors has been a significant driver of the CRISPR technology patent industry. These financial infusions have provided critical support for the research, development, and commercialization of CRISPR-based goods and therapies, accelerating market penetration. Moreover, the increasing prevalence of genetic abnormalities has emerged as a major motivator for the use of CRISPR technology, notably in medicine. As the prevalence of genetic diseases rises, so does the demand for precise and effective gene-editing techniques, underlining CRISPR-based therapies' considerable potential in treating genetic disorders.
Increasing Development of New Vaccines and Treatment of Genetic Diseases is Expected to Propel CRISPR Technologies Patent Industry Demand
The discovery of new vaccinations and treatments for genetic illnesses utilizing CRISPR technology represents a game-changing prospect in the realm of healthcare. CRISPR's precise gene editing capabilities have enormous potential for treating infectious diseases and resolving the genetic origins of many maladies. This possibility not only promises new ways to prevent and treat diseases but also transforms the way we approach healthcare treatments. Editas Medicine is undertaking a phase 1/2 experiment for severe sickle cell disease (SCD) using a CRISPR method with Cas12a protein instead of the well-known Cas9 protein. Furthermore, Vertex Pharmaceuticals and CRISPR Therapeutics are collaborating on Beta-thalassemia.
The report will cover the following sections in detail:
Analysis by Type
Analysis by Application
The breakup based on type includes products and services. The product segment (CRISPR kits and enzymes) dominates the market. Enzymes and CRISPR kits are critical for developing disease models for scientific research. Scientists can reproduce ill conditions in cells or organisms by introducing genetic defects associated with diseases. This strategy is beneficial for determining the causes of diseases and evaluating potential therapies.
The United States is one of the leading jurisdictions for CRISPR technology patents, having around 34,900+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.
Among the players within CRISPR technologies patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the CRISPR technologies field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
Wuhan Bowo Innovation Biotechnology Co., Ltd. is a biotechnology company based in Wuhan, China, specializing in gene editing technologies, particularly CRISPR/Cas9 and related applications. The company focuses on developing innovative solutions in areas such as genetic engineering, molecular biology, and therapeutic applications.
Monsanto Technology LLC, a subsidiary of Bayer AG, is a leading agricultural biotechnology company known for i...
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Excision Biotherapeutics Inc., Pioneer Hi Bred Int, and Crispr Therapeutics Ag, among others.
The CRISPR technologies patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
Scope of the Report |
Details |
Analysis by Product Type |
|
Analysis by Application |
|
Key Players Mentioned |
|
Geographies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share